Inomagen Therapeutics, Inc.

Form D Filings

Location
Chicago, IL
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001626370
Previous Names
Inomagen Therapeutics, Inc., Rhythm Therapeutics, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
6/20/2025 Equity $140,000 $3,778,984 $3,638,984 6/5/2025 6/19/2025 D 000162637025000002
4/12/2024 Equity, Option to Acquire, Security to be Acquired $200,000 $6,626,079 $6,426,079 3/29/2024 4/12/2024 D 000162637024000003
11/24/2014 Debt $200,000 $400,000 $200,000 11/12/2014 11/21/2014 D 000162637014000001